HONG KONG, Jan. 2, 2013 (GLOBE NEWSWIRE) -- Bonso Electronics International, Inc. (Nasdaq:BNSO) today reported its financial results for the six-month period ended September 30, 2012.
Bonso reported a net income for the six-month period ended September 30, 2012 of $0.13 million or $0.02 basic and diluted earnings per share, as compared to a net loss of $0.18 million or $0.03 basic and diluted loss per share posted during the six-month period ended September 30, 2011. Net sales for the six-month period ended September 30, 2012increased 16.5% to $16.3 million from $14.0 million for the six-month period ended September 30, 2011.
Mr. Anthony So, President and CEO stated: "Along with the $2.3 million increase in revenue, we are very pleased with the improvement in our gross profit margin from 16.1% for the six month period ended September 30, 2011 to 18.4% for the comparable period in 2012. We accomplished the improvement in our gross profit even though raw material costs and labor costs were higher. We expect the demand for our products will continue to increase in calendar year 2013."
About Bonso Electronics
Bonso Electronics designs, develops, manufactures, assembles and markets a comprehensive line of electronic scales, weighing instruments, and health care products. Bonso products are manufactured in the People's Republic of China for customers primarily located in North America and Europe. Company services include product design and prototyping, production tooling, procurement of components, total quality management, and just-in-time delivery. Bonso also independently designs and develops electronic products for private label markets. For further information, visit the company's web site at http://www.bonso.com.
This news release includes forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. Forward looking statements may be identified by such words or phrases as ``should,'' ``intends,'' ``is subject to,'' ``expects,'' ``will,'' ``continue,'' ``anticipate,'' ``estimated,'' ``projected,'' ``may,'' `` I or we believe,'' ``future prospects,'' or similar expressions. Forward-looking statements made in this press release, which relate to the the demand for our products, among other things,involve known and unknown risks and uncertainties that may cause the actual results to differ materially from those expected and stated in this announcement. We undertake no obligation to update "forward-looking" statements.
-- Tables to Follow –
| Consolidated Balance Sheets | ||
| (Expressed in United States Dollars) | ||
| September 30 | March 31 | |
| 2012 | 2012 | |
| $ in thousands | $ in thousands | |
| (unaudited) | (Audited) | |
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | 2,004 | 3,014 |
| Trade receivables, net | 2,494 | 2,081 |
| Inventories | 4,350 | 4,105 |
| Income tax recoverable | 2,043 | 1,903 |
| Other receivables, deposits and prepayments | 1,081 | 1,104 |
| Total current assets | 11,972 | 12,207 |
| Brand name and other intangible assets, net | 4,670 | 3,990 |
| Property, plant and equipment, net | 7,666 | 6,971 |
| Total assets | 24,308 | 23,168 |
| Liabilities and stockholders' equity | ||
| Current liabilities | ||
| Notes payable | 2,883 | 1,870 |
| Accounts payable | 5,572 | 5,032 |
| Accrued charges and deposits | 1,926 | 2,347 |
| Income tax liabilities | 26 | 44 |
| Total current liabilities | 10,407 | 9,293 |
| Income tax liabilities | 2,597 | 2,595 |
| Deferred income tax liabilities | -- | 2 |
| Stockholders' equity | ||
| Common stock par value $0.003 per share | ||
| - authorized shares - 23,333,334 | ||
| - issued shares: Sep 30, 2012 and Mar 31, 2012 -- 5,577,639, | 17 | 17 |
| outstanding shares: Sep 30, 2012 and Mar 31, 2012 – 5,246,903 shares | ||
| Additional paid-in capital | 21,765 | 21,765 |
| Treasury stock at cost: Sep 30, 2012 and Mar 31, 2012 - 330,736 shares | (1,462) | (1,462) |
| Accumulated deficit | (11,708) | (11,834) |
| Accumulated other comprehensive income | 2,692 | 2,792 |
| 11,304 | 11,278 | |
| Total liabilities and stockholders' equity | 24,308 | 23,168 |
| Consolidated Statements of Operations and Comprehensive Loss | ||
| (Expressed in United States Dollars) | ||
|
Six months ended September 30, 2012 |
Six months ended September 30, 2011 |
|
| $ in thousands | $ in thousands | |
| (unaudited) | (unaudited) | |
| Net sales | 16,276 | 13,975 |
| Cost of sales | (13,274) | (11,730) |
| Gross profit | 3,002 | 2,245 |
| Selling expenses | (347) | (274) |
| Salaries and related costs | (1,078) | (991) |
| Research and development expenses | (279) | (228) |
| Administration and general expenses | (1,165) | (942) |
| Income / (loss) from operations | 133 | (190) |
| Interest income | 3 | 2 |
| Interest expenses | (33) | (18) |
| Foreign exchange loss | (22) | (9) |
| Other income | 45 | 33 |
| Net income / (loss) | 126 | (182) |
| Other comprehensive income, net of tax: | ||
| Foreign currency translation adjustments, net of tax | (100) | 135 |
| Comprehensive income / (loss) | 26 | (47) |
| Earnings / (loss) per share | ||
| Weighted average number of shares outstanding | 5,246,903 | 5,246,903 |
| Earnings per share ( in U.S.Dollars per share) | ||
| - basic and diluted | 0.02 | (0.03) |
The diluted net loss per share was the same as the basic net loss per share for the six-month periods ended September 30, 2012 and September 30, 2011 as all potential ordinary shares including the stock options and warrants are anti-dilutive and are therefore excluded from the computation of diluted net loss per share.